Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany

Bacillus Calmette-Guérin (BCG) vaccine is known to have “bystander benefits” in protecting against heterologous infections; interim analysis of the “ACTIVATE” trial shows protection against respiratory infections in the elderly population. Epidemiologic studies suggest a potential benefit of BCG vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Hernández, Daniela, Nixon, Douglas F., Hupert, Nathaniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475553/
https://www.ncbi.nlm.nih.gov/pubmed/33544024
http://dx.doi.org/10.1080/21645515.2021.1872344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475553/
https://www.ncbi.nlm.nih.gov/pubmed/33544024
http://dx.doi.org/10.1080/21645515.2021.1872344

Ejemplares similares